Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

por Kustin, Talia, Harel, Noam, Finkel, Uriah, Perchik, Shay, Harari, Sheri, Tahor, Maayan, Caspi, Itamar, Levy, Rachel, Leshchinsky, Michael, Ken Dror, Shifra, Bergerzon, Galit, Gadban, Hala, Gadban, Faten, Eliassian, Eti, Shimron, Orit, Saleh, Loulou, Ben-Zvi, Haim, Keren Taraday, Elena, Amichay, Doron, Ben-Dor, Anat, Sagas, Dana, Strauss, Merav, Shemer Avni, Yonat, Huppert, Amit, Kepten, Eldad, Balicer, Ran D., Netzer, Doron, Ben-Shachar, Shay, Stern, Adi
Publicado 2021

Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)

por Katz, Mark A., Harlev, Efrat Bron, Chazan, Bibiana, Chowers, Michal, Greenberg, David, Peretz, Alon, Tshori, Sagi, Levy, Joseph, Yacobi, Mili, Hirsch, Avital, Amichay, Doron, Weinberger, Ronit, Dor, Anat Ben, Taraday, Elena Keren, Reznik, Dana, Chayat, Chen Barazani, Sagas, Dana, Zvi, Haim Ben, Berdinstein, Rita, Rashid, Gloria, Avni, Yonat Shemer, Mandelboim, Michal, Zuckerman, Neta, Rainy, Nir, Akriv, Amichay, Dagan, Noa, Kepten, Eldad, Barda, Noam, Balicer, Ran D.
Publicado 2022